Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Maite Vidán"'
Autor:
Oriol Alegre, Francisco Marín, Longevo-Sca registry investigators, Pablo Díez-Villanueva, Albert Ariza-Solé, Alberto Vera, Maite Vidán, Francesc Formiga, Héctor Bueno, Juan Sanchis, Ramón López-Palop, Manuel Martínez-Sellés, Emad Abu-Assi, Fernando Alfonso
Publikováno v:
International Journal of Clinical Practice. 75
Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We sought to study if this score predicts outcomes in elderly patients with Non-ST segment Elevation Acute Coronary Syndromes (NSTE
Autor:
Pablo, Díez-Villanueva, Alberto, Vera, Albert, Ariza-Solé, Francesc, Formiga, Manuel, Martínez-Sellés, Oriol, Alegre, Juan, Sanchís, Francisco, Marín, Maite, Vidán, Ramon, López-Palop, Emad, Abu-Assi, Héctor, Bueno, Fernando, Alfonso
Publikováno v:
International journal of clinical practiceREFERENCES. 75(6)
CHAThe multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEACS aged ≥80 years. Data to calculate CHAA total of 266 patients (51%) had a high CHAA CHA
Autor:
José Antonio Serra-Rexach, Maite Vidán-Astiz, Javier Ortiz-Alonso, Lydia Abasolo, Nuria Montero-Fernández, Jennifer Mayordomo-Cava
Publikováno v:
The Journal of arthroplasty. 35(5)
Objectives The number of nonagenarian patients with hip fracture is increasing. The goals of this study were to describe the characteristics and in-hospital course of a cohort of 1177 nonagenarians admitted for hip fracture compared with younger pati
Publikováno v:
Revista Española de Geriatría y Gerontología. 49:223-227
Resumen Objetivo Desarrollar un indice capaz de estimar el riesgo individual de muerte a los 6 meses y un ano, de los pacientes dados de alta de una Unidad de Agudos de Geriatria. Metodologia y analisis Estudio cohorte, prospectivo. Pacientes mayores
Autor:
Carmen María Osuna-Pozo, Guillermo Ferreira, Javier Ortiz-Alonso, José Antonio Serra-Rexach, Maite Vidán
Publikováno v:
Revista Española de Geriatría y Gerontología. 49:77-89
Hospitalization is a risk for elderly population, with a high probability of having adverse events. The most important one is functional impairment, due to its high prevalence and the serious impact it has on the quality of life. The main risk factor
Autor:
Jennifer Mayordomo-Cava, Javier Ortiz-Alonso, Nuria Montero-Fernández, L. Abásolo Alcazar, Maite Vidán-Astiz, José Antonio Serra-Rexach
Publikováno v:
Revista Española de Geriatría y Gerontología. 53:39-40
Autor:
Ana Belén Jiménez, Pilar García-Alfonso, Javier Ortiz, Rosa Pla, Paz Rodríguez, Maite Vidán, José Antonio Serra-Rexach, María A. García-Alhambra, Miguel Martín
Publikováno v:
The Oncologist. 17:1277-1285
Learning Objectives After completing this course, the reader will be able to: Use patient age as only one consideration, along with tumor status and comorbidities, in deciding on treatment strategies for elderly colorectal cancer patients.Obtain and
Autor:
L. Abásolo-Alcázar, Maite Vidán-Astiz, Nuria Montero-Fernández, Javier Ortiz-Alonso, José Antonio Serra-Rexach, J. Cava-Mayordomo
Publikováno v:
Revista Española de Geriatría y Gerontología. 53:104
Autor:
Gregorio Jiménez Díaz, José María Jiménez Páez, Maite Vidán Astiz, Inés Francés Román, Nuria Pilar Montero Fernández, Javier Gómez-Pavón, José Gutiérrez Rodríguez, Paloma González García, Baldomero Álvarez Fernández
Publikováno v:
Revista Española de Geriatría y Gerontología. 45:89-96
The elderly are one of the groups at greatest risk for adverse drugs reactions (ADR). The mean prevalence of these reactions in this population is 30%. Dementia is not an independent risk factor of ADR, but is the main condition that increases all ri
Autor:
César Hernández-García, Benjamín Fernández-Gutiérrez, José R. Regueiro, A Bañares, Mercedes Pérez-Blas, Maite Vidán, José Antonio Serra, Josep-Maria Ribera, Juan Angel Jover
Publikováno v:
Age and Ageing. 28:221-227
Introduction: the antigen CD28, expressed in most T cells, has co-stimulatory properties and plays a pivotal role in clonal T cell anergy mechanisms. Methods: we have compared proliferative T cell responses after anti-CD3 or in phorbol myristate acet